Moderna, Inc. (MRNA)
October 8, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against - MRNA
NEW YORK, NY / ACCESSWIRE / September 13, 2024 / If you suffered a loss on your Moderna, Inc. (NASDAQ:MRNA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
Moderna's spending cuts, pipeline shakeup leave doubts about a rebound, analysts say
Moderna's cost-reduction plans, pipeline cuts and reined-in financial guidance, unveiled Thursday, triggered a wave of downgrades as analysts focused on longer timelines to launch some products and questioned when the company can return to profitability.
Moderna Inc May Have Violated Securities Laws And Affected Stockholders Are Urged To Contact The Schall Law Firm About A Suit
LOS ANGELES, CA / ACCESSWIRE / September 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Moderna, Inc. ("Moderna" or "the Company") (NASDAQ:MRNA) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 18, 2023 and June 25, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before October 8, 2024.
Tradepulse Power Inflow Alert: Moderna Inc. Rises 8.9% On The Trading Day
MRNA RECEIVES SIGNAL AT 10:21 AND RISES THROUGHOUT THE DAY
Moderna stock plunges nearly 20% as company reports poor COVID-19 vaccine sales and cuts to research plans
Moderna (NYSE: MRNA) stock plunged Thursday on news it will be slashing its research and development (R&D) budget by about 20% over the next three years, a result of low sales projections and poor vaccine sales.
Moderna Stock Falls Again. How the Drug Maker Can Turn Things Around.
Analysts come up with their key catalyst watch list that can help Moderna shares get out of the rut.
A Bull Market Is Here: 2 High-Potential Stocks Down More Than 50% to Buy Right Now
Moderna may have a number of new product launches ahead. Pfizer is a big pharma stock that's poised for a big comeback.
Investors who Lost Money on Moderna, Inc. (MRNA) Should Contact Levi & Korsinsky About Pending Class Action - MRNA
NEW YORK, NY / ACCESSWIRE / September 13, 2024 / If you suffered a loss on your Moderna, Inc. (NASDAQ:MRNA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
MRNA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of Moderna, Inc. to Contact the Firm Today!
NEW YORK CITY, NY / ACCESSWIRE / September 13, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Moderna, Inc. ("Moderna" or "the Company") (NASDAQ:MRNA) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Moderna securities between January 18, 2023, and June 25, 2024, inclusive (the "Class Period").
S&P 500 Gains and Losses Today: Moderna Stock Plunges as Firm Plans R&D Cuts
Major U.S. equities indexes headed higher after the latest Producer Price Index (PPI) report showed a cooldown in wholesale inflation in August, the latest data point that could tip the scales toward an interest-rate cut when the Federal Reserve meets next week.
Class Action Filed Against Moderna, Inc. (MRNA) - October 8, 2024 Deadline to Join - Contact Levi & Korsinsky
NEW YORK, NY / ACCESSWIRE / September 12, 2024 / If you suffered a loss on your Moderna, Inc. (NASDAQ:MRNA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
Levi & Korsinsky Reminds Moderna, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 8, 2024 - MRNA
NEW YORK, NY / ACCESSWIRE / September 12, 2024 / If you suffered a loss on your Moderna, Inc. (NASDAQ:MRNA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
